Literature DB >> 12825803

The effects of hyperhomocysteinemia on the presence, extent, and severity of coronary artery disease.

Abdi Bozkurt1, Hale Toyaksi, Esmeray Acartürk, Abdullah Tuli, Murat Cayli.   

Abstract

Most cross-sectional and case-control studies indicate that an increased plasma total homocysteine (tHcy) level is an independent risk factor for coronary artery disease (CAD). However, this is still a controversial issue. Recently, it was reported that the level of tHcy is related to the extent and severity of CAD. This study was designed to investigate the relationship between plasma tHcy levels and the presence, extent, and severity of CAD. Three hundred and forty-one patients who underwent coronary angiography were included in the study. Of these patients, 195 had CAD and 146 had normal coronary arteries (control group). The mean tHcy level was found to be higher in patients with significant CAD (16.4 +/- 7.4 micromol/L vs 13.2 +/- 3.6 micromol/L, P < 0.001). This group also had a higher rate of hyperhomocysteinemia (HHcy) (22.6% vs 5.5%, P < 0.001). There were positive relationships between tHcy levels and male gender (P = 0.03, r = 0.16), smoking (P < 0.001, r = 0.19), hyperlipidemia (P = 0.006, r = 0.15), and hypertension (P < 0.001, r = 0.20). Using regression analysis HHcy was determined to be an independent risk factor for CAD (OR = 3.69, CI 95% 1.51-9.06, P = 0.004). However, HHcy was not an independent risk factor in patients with low cardiovascular risk profiles. There was no relationship between the level of tHcy and the severity, extent, and vessel scores of CAD. On the other hand, age and diabetes mellitus were related with all scores of CAD. In conclusion, although hyperhomocysteinemia is an independent risk factor for CAD in our region, it appears to be unrelated to the extent and severity of the disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12825803     DOI: 10.1536/jhj.44.357

Source DB:  PubMed          Journal:  Jpn Heart J        ISSN: 0021-4868


  5 in total

1.  Polymorphism in the methylenetetrahydrofolate reductase (C677T) gene and homocysteine levels: a comparison in Brazilian patients with coronary arterial disease, ischemic stroke and peripheral arterial obstructive disease.

Authors:  Adriano Sabino; Ana Paula Fernandes; Luciana Moreira Lima; Daniel Dias Ribeiro; Marinez Oliveira Sousa; Maria Elizabeth Rennó de Castro Santos; Ana Paula Lucas Mota; Luci Maria Sant'Ana Dusse; Maria das Graças Carvalho
Journal:  J Thromb Thrombolysis       Date:  2007-11-27       Impact factor: 2.300

2.  Homocysteine-induced enhanced expression of tissue factor in human vascular smooth muscle cells.

Authors:  Fang Liu; Ruibin Huang; Junxia Yao; Wenning Wei; Yu Hu; Shanjun Song; Jun Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-10-10

3.  Hyperhomocysteinemia in a young woman presenting with acute myocardial infarction: Case report.

Authors:  Seher Gokay; Davran Ciçek; Haldun Müderrisoğlu
Journal:  Interv Med Appl Sci       Date:  2013-03-19

4.  Sortilin and Homocysteine as Potential Biomarkers for Coronary Artery Diseases.

Authors:  Rehab H Werida; Ayman Omran; Noha M El-Khodary
Journal:  Int J Gen Med       Date:  2021-09-27

5.  5,10-methylene tetrahydrofolate reductase C677T gene polymorphism, homocysteine concentration and the extent of premature coronary artery disease in southern Iran.

Authors:  Sara Senemar; Babak Saffari; Mohammad Bagher Sharifkazemi; Marzieh Bahari; Najmeh Jooyan; Elham Davoudi Dehaghani; Majid Yavarian
Journal:  EXCLI J       Date:  2013-05-16       Impact factor: 4.068

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.